Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
The company maintains a cost and scale advantage in the aliphatic amines niche, corroborated by high average ROCE (21.6%) and a dominant domestic position. High switching costs for pharmaceutical and agrochemical clients, who view these amines as critical but low-cost 'C-items,' provide significant pricing power during inflationary periods.
Earnings are consistently reinvested into high-return brownfield expansions and R&D-led specialty products, while maintaining a conservative debt-to-equity ratio of 0.16. The company balances growth with a steady 500% dividend payout, demonstrating disciplined capital management.
The investment collapsed because the company's niche dominance was eroded by aggressive domestic capacity expansion from competitors like Aarti Drugs, turning a high-margin specialty business into a low-margin commodity trap. While management focused on brownfield expansions, the 2026 ammonia force majeure and geopolitical distributor sanctions permanently disrupted the supply chain, allowing rivals to seize market share. The resulting margin compression, coupled with the expiration of anti-dumping protections, revealed that the 'pricing power' was merely a temporary artifact of supply shortages rather than a durable competitive advantage.
RichFakir rates Alkyl Amines Chemicals Ltd's business quality as wonderful — 76/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, Alkyl Amines Chemicals Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Alkyl Amines Chemicals Ltd is: Watch — wait for price. A wonderful business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of Alkyl Amines Chemicals Ltd's fair value is about ₹628 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →